Journal of Nanomedicine & Nanotechnology

New trends in nanotechnology-based targeted drug delivery systems

15^th World Medical Nanotechnology Congress

October 18-19, 2017 Osaka, Japan

Hussein O Ammar

Future University, Egypt

Keynote: J Nanomed Nanotechnol

Abstract:

In recent years, theranostics are emerging as the next generation of multifunctional nanomedicine to improve the therapeutic outcome of cancer therapy. Polymeric nanoparticles with targeting moieties containing magnetic nanoparticles as theranostic agents have considerable potential for the treatment of cancer. The use of directed enzyme prodrug therapy (DEPT) has been investigated as a means to improve the tumor selectivity of therapeutics. Magnetic DEPT involves coupling the bioactive prodrug-activating enzyme to magnetic nanoparticles that are then selectively delivered to the tumor by applying an external magnetic field. Gene therapy is an attractive method for meeting the needs for curing brain disorders, such as Alzheimer�??s disease and Parkinson�??s disease. On the other hand, due to the fact that hepatocellular carcinoma (HCC) is resistant to standard chemotherapeutic agents, gene therapy appears to be a more effective cure for HCC patients. Ultrasound-mediated drug delivery is a novel technique for enhancing the penetration of drugs into diseased tissue beds non-invasively. This technique is broadly appealing, given the potential of ultrasound to control drug delivery spatially and temporally in a non-invasive manner.

Biography :

Hussein O Ammar is currently the Chairman, Pharmaceutical Technology Department, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt; formerly, Dean of the Pharmacy Division, National Research Centre, Cairo, Egypt. He holds the First Class Golden Medal for Sciences and Arts and the recipient of the 2010 Appreciation State Prize in the realm of Advanced Technological Sciences. He has more than 110 research papers published in international scientific journals.